Composition and diversity of gut microbiota in diabetic retinopathyOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined the composition, structure, and function of gut microbiota in patients with diabetic retinopathy (DR), a common complication of type 2 diabetes mellitus. Researchers used 16S ribosomal RNA gene sequencing on stool samples to characterize microbial community differences. They also explored correlations between gut microbiota features and the clinical characteristics of DR.
Who was studied?
The study included 50 total participants who provided stool samples: 25 patients with diabetic retinopathy and 25 healthy controls. DNA was extracted from the fecal samples and analyzed using the MiSeq sequencing platform. No further demographic details were given in the abstract.
What were the most important findings?
The gut microbial structure and composition of DR patients differed from that of healthy controls, and microbial richness was higher in the DR group. These alterations were associated with disrupted levels of the Firmicutes, Bacteroidetes, Synergistota, and Desulfobacterota phyla. At the genus level, Bacteroides, Megamonas, Ruminococcus_torques_group, Lachnoclostridium, and Alistipes were increased, while Blautia, Eubacterium_hallii_group, Collinsella, Dorea, Romboutsia, Anaerostipes, and Fusicatenibacter were decreased in DR patients. Notably, the Desulfobacterota phylum, which includes sulfate-reducing bacteria capable of hydrogen sulfide production, was among the disrupted taxa in DR.
What are the greatest implications of this study?
These findings suggest that gut microbiota alterations, including shifts in sulfate-reducing Desulfobacterota, may be linked to the development or progression of diabetic retinopathy. The distinct microbial signature identified in DR patients raises the possibility that gut microbiota could serve as a biomarker or contributing factor in this diabetic complication. Further research building on the stochastic forest model mentioned in the abstract could help clarify whether specific taxa have diagnostic or mechanistic relevance to DR.